NSIS B — Novozymes A/S Share News
0.000.00%
Last trade - 00:00- DKK212.05bn
- DKK232.64bn
- €4.16bn
Europe Research Roundup: Danske Bank, Entain, Halma
GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo
Europe Research Roundup: Hargreaves Lansdown, Segro, Umicore
Brief: Novonesis CFO: Slow Regulatory Approvals Are Main Obstacle To Growth
Novonesis jumps on outlook hike fuelled by rising biosolutions demand
Brief: Novozymes Says 2024 Outlook Of Pro Forma Organic Sales Growth Now Expected At Upper End Of 5-7% Range
Novonesis shares jump after Q1 household care growth beats expectations
Brief: Novonesis Maintains 2024 Outlook
Europe Research Roundup: Admiral, Auto Trader, BBVA
Novonensis expects 2024 adjusted EBITDA margin of 35% (updated)
Novonensis expects 2024 adjusted EBITDA margin of 35%
Brief: Novozymes Expects Organic Sales Growth Of 5-7% In 2024
Bernstein sees normalising consumer chemicals growth in 2024
Novo Nordisk-owner to expand in India this year
Brief: Novozymes: 2024 Outlook Wil Be Provided No Later Than March 31
Brief: Novozymes Q4 EBITDA DKK 1,320 Million
Earnings Poll: Novozymes fourth quarter results due on February 1
Jefferies sees above peer growth for Novozymes, ups to 'buy'
Brief: Combination Of Novozymes, Chr. Hansen Is Completed